Adma Biologics reported $14K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Adma Biologics ADMA:US $ 0.01M 0M
Agile Therapeutics AGRX:US $ 0.01M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.2M 0.01M
Dynavax Technologies DVAX:US $ 0.12M 0.01M
Kindred Biosciences KIN:US $ 0M 0M
Minerva Neurosciences NERV:US $ 0M 0M
Novavax NVAX:US $ 0.76M 0.01M
Omeros OMER:US $ 625K 1000
Takeda 4502:JP Y 1676263M 7138M